Hofseth BioCare ASA — Proxy Solicitation & Information Statement 2014

May 2, 2014

Hofseth Biocare ASA : Proxies to vote for 54,44% of the shares at EGM

Hofseth Biocare ASA : Proxies to vote for 54,44% of the shares at EGM

The board in Hofseth BioCare has received proxies to vote for 32 177 735 shares

corresponding to 41,5% of total shares outstanding at the company's

extraordinary general meeting 2 May 2014.

CFO Øystein Omvik in Hofseth BioCare has received proxies to vote for 6 182 997

shares, corresponding to 7,97 % of total shares outstanding, at the company's

extraordinary general meeting 2 May 2014.

Roger Hofseth has received proxies to vote for 3 850 000 shares, corresponding

to 4,97 % of total shares outstanding, at the company's extraordinary general

meeting 2 May 2014.

About Hofseth BioCare

Hofseth BioCare is a Norwegian biotech company that offers high-value

ingredients and finished products for humans and pets. The company is founded on

the core values of sustainability, traceability and optimal utilization of

natural resources. Through an innovative hydrolysis technology, Hofseth BioCare

is able to preserve the quality of salmon oil, proteins and calcium, prepared of

fresh salmon off-cuts. HBCs objective is to contribute to the efficient use of

marine resources and deliver quality products for ingredients and finished

consumer products in the nutrition market.

This information is subject of the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

[HUG#1782223]